SCHEMBL13725129

SCHEMBL13725129

CC(=O)Nc1ccc2c(c1)C1C=CCC1C(C(=O)O)N2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 14/20 1.00
HSPA1A P0DMV8 13/20 1.00
NR4A1 P22736 3/20 1.00
POLB P06746 7/20 0.73
KMT2A Q03164 7/20 0.73
ALDH1A1 P00352 4/20 0.73
L3MBTL1 Q9Y468 4/20 0.73
MASP2 O00187 3/20 0.73
MCL1 Q07820 3/20 0.73
GAA P10253 3/20 0.73
USP2 O75604 2/20 0.73
NSD2 O96028 1/20 0.73
ALPL P05186 1/20 0.73
APOBEC3A P31941 1/20 0.73
APOBEC3G Q9HC16 1/20 0.73
GAPDH P04406 9/20 0.69
MEN1 O00255 6/20 0.69
BLM P54132 4/20 0.69
TDP1 Q9NUW8 3/20 0.69
MAPT P10636 3/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16706084 0.84 POLB (1.00) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL13186581 0.79 PTPN7 (0.73) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL2808722 0.79 PTPN7 (1.00) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL16706087 0.79 PTPN7 (1.00) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL25602294 0.76 USP7 (0.67) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL31492743 0.76 PTPN7 (1.00) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL26098723 0.76 PTPN7 (1.00) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL17211738 0.75 HSPA1A (0.81) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL15033517 0.74 POLB (1.00) PTPN7HSPA1ANR4A1POLBKMT2A
SCHEMBL1066515 0.74 PTPN7 (1.00) PTPN7HSPA1ANR4A1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 US disclosed
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 US disclosed
WO-2009073550-A2 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS NISCH, NDUFS3, SDHA PTPN7 3898/4885HSPA1A 581/4885NR4A1 2797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.